Skip to main content
. 2022 Apr 10;14(8):1919. doi: 10.3390/cancers14081919

Table 4.

Management recommendations for suspected neurotoxicity during immunotherapy with DB.

  • Stop DB infusion/immunotherapy

  • Start antibacterial and antiviral therapy for potential infectious cause

  • Examine for VZV and HSV infection (PCR of blood and CSF)

  • Rule out other cause for neurological symptoms by cMRI, MRI of spinal cord and evaluate metabolic conditions

  • EEG if clinically indicated

  • Carry out CSF examination

  • Urgently start immunosuppression with dexamethasone or prednisolone and IVIG

  • In case of no improvement of symptoms, consider plasmapheresis

DB, dinutuximab beta; cMRI, cardiac magnetic resonance imaging; CSF, cerebrospinal fluid; EEG, electroencephalogram; HSV, herpes simplex virus; IVIG, intravenous immunoglobulins; MRI, magnetic resonance imaging; PCR, polymerase chain reaction; VZV, varicella zoster virus.